TNF and rheumatoid arthritis: As above concepts for pathogenesis of RA, clinical application with TNF-α-neutralizing antibody and IL-1 receptor antagonist exhibits substantial efficacy but carries the disadvantages of high cost, hypersensitivity to medications, and possibility of serious infections [7, 8].